ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
125.571,81
0,76%
S&P 500
6.066,44
0,67%
US Dollar vs BRL
5,7886
-0,30%
Bitcoin
97.457,08
1,00%
Brent Oil
75,925
1,75%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Neuropace Inc (NPCE)

  7. Neuropace Inc (NPCE) Notícias

NPCE

Neuropace (NPCE)

Neuropace Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NPCE
DataHoraFonteTítuloCódigoCompanhia
31/01/202521:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NPCENeuropace Inc
30/01/202518:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NPCENeuropace Inc
28/01/202519:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NPCENeuropace Inc
14/11/202417:36Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NPCENeuropace Inc
12/11/202419:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NPCENeuropace Inc
04/11/202418:51Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NPCENeuropace Inc
05/03/202419:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NPCENeuropace Inc
14/02/202418:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NPCENeuropace Inc
19/07/202317:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NPCENeuropace Inc
28/06/202317:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NPCENeuropace Inc
14/06/202318:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NPCENeuropace Inc
04/05/202317:05GlobeNewswire Inc.NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue GuidanceNASDAQ:NPCENeuropace Inc
25/04/202318:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NPCENeuropace Inc
25/04/202318:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NPCENeuropace Inc
17/04/202317:05GlobeNewswire Inc.NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023NASDAQ:NPCENeuropace Inc
03/04/202317:05GlobeNewswire Inc.NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare ConferenceNASDAQ:NPCENeuropace Inc
02/03/202319:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NPCENeuropace Inc
02/03/202318:05GlobeNewswire Inc.NeuroPace Reports Fourth Quarter & Full Year 2022 Financial ResultsNASDAQ:NPCENeuropace Inc
14/02/202319:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NPCENeuropace Inc
10/02/202315:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NPCENeuropace Inc
10/02/202310:00GlobeNewswire Inc.NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023NASDAQ:NPCENeuropace Inc
09/01/202318:29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NPCENeuropace Inc
09/01/202318:03GlobeNewswire Inc.NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of DirectorsNASDAQ:NPCENeuropace Inc
21/12/202218:03GlobeNewswire Inc.NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:NPCENeuropace Inc
30/11/202210:00Business WireNeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now UnderwayNASDAQ:NPCENeuropace Inc
23/11/202219:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NPCENeuropace Inc
21/11/202209:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NPCENeuropace Inc
08/11/202218:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NPCENeuropace Inc
08/11/202218:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NPCENeuropace Inc
08/11/202218:03GlobeNewswire Inc.NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:NPCENeuropace Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NPCE

Seu Histórico Recente

AQSE
XSPX.GB
Deutsche Bank Luxembourg
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios